HT
CODX

HAP Trading’s Co-Diagnostics CODX Stock Holding History

HAP Trading’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-370
Closed -$5K – 2303
2021
Q4 		$5K Buy
+370
New +$97.1K ﹤0.01% 2218
2021
Q3 		– Sell
-463
Closed -$11K – 2473
2021
Q2 		$11K Buy
+463
New +$119K ﹤0.01% 1967
2021
Q1 		– Sell
-830
Closed -$4K – 1989
2020
Q4 		$4K Buy
830
+283
+52% +$105K ﹤0.01% 2050
2020
Q3 		$64K Buy
547
+10
+2% +$5.14K ﹤0.01% 904
2020
Q2 		$10K Buy
+537
New +$245K ﹤0.01% 1447

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

HAP Trading's CODX Position: Q1 2021 in Review

HAP Trading sold out of Co-Diagnostics (CODX) in Q1 2021, closing a stake of 955 shares — an estimated $266K sold.

HAP Trading first reported a position in CODX in Q2 2020 and held it in 2 quarters. The position peaked at $297K in Q2 2020. 95 funds tracked by Wall St. Rank hold CODX as of Q1 2021.

  • HAP Trading reported no remaining Co-Diagnostics position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 955 Co-Diagnostics shares in Q1 2021, an estimated $266K.
  • HAP Trading first reported a position in Co-Diagnostics in Q2 2020 and held it in 2 quarters.
  • HAP Trading's Co-Diagnostics position peaked at $297K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.